• ProMetic Life Sciences Inc., of Laval, Quebec, said a stakeholder has invested a further C$1 million (US$1 million) in equity. The firm also restructured the repayment of C$4 million in secured loans, deferring payment until July 1, 2013. Those two transactions are expected to allow the company an opportunity to repay its loans with anticipated revenues generated from commercial transactions.